Video

Major Trends Impacting Allogeneic Cell Therapies for Oncology

Source: Cell & Gene

We kicked off this Cell & Gene Live, Unlocking the Future of Allogeneic Cell Therapy for Oncology, featuring Cokey Nguyen, Ph.D. EVP, Chief Scientific & Technical Officer at Atara Bio and Loren Wagner, COO at Poseida Therapeutics by discussing the major trends impacting allogeneic cell therapies for oncology. Watch this segment to learn why Nguyen and Wagner agree that regulatory success, better efficiency, better durability, and how hallogeneic therapies are superior in terms of their ability to meet an intent to treat population.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests: